Design and Rational of the OPTIMA Study: Retreatment or Step-Up Therapy With Omalizumab in Patients With Chronic Idiopathic Spontaneous Urticaria (CIU CSU). J of Skin 2017, 1 (3.1), s125. https://doi.org/10.25251/skin.1.supp.124.